Source: Circulation. Unidade: FM
Subjects: SEGUIMENTOS, PROGNÓSTICO, CARDIOPATIAS (CIRURGIA;TERAPIA), CORONARIOPATIA (TERAPIA)
ABNT
HUEB, Whady et al. Ten-year follow-up survival of the Medicine, Angioplasty or Surgery Study (MASS II): A randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation, v. 122, n. 10, p. 949-957, 2010Tradução . . Acesso em: 19 out. 2024.APA
Hueb, W., Lopes, N., Gersh, B. J., Soares, P. R., Ribeiro, E. E., Pereira, A. C., et al. (2010). Ten-year follow-up survival of the Medicine, Angioplasty or Surgery Study (MASS II): A randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation, 122( 10), 949-957.NLM
Hueb W, Lopes N, Gersh BJ, Soares PR, Ribeiro EE, Pereira AC, Favarato D, Rocha ASC, Hueb AC, Ramires JAF. Ten-year follow-up survival of the Medicine, Angioplasty or Surgery Study (MASS II): A randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation. 2010 ; 122( 10): 949-957.[citado 2024 out. 19 ]Vancouver
Hueb W, Lopes N, Gersh BJ, Soares PR, Ribeiro EE, Pereira AC, Favarato D, Rocha ASC, Hueb AC, Ramires JAF. Ten-year follow-up survival of the Medicine, Angioplasty or Surgery Study (MASS II): A randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation. 2010 ; 122( 10): 949-957.[citado 2024 out. 19 ]